Avid Bioservices Inc (CDMO)

[exwannabe]

But, for some reason Bavi/3mg at ORR=17.9% (double+) is “failing to meet its primary endpoint” to you**?

Because or the size of the trial, the Bavi ORR data has a P value of about .3 (for the high dose arm, higher for the low dose arm).

The Tarceva trial does not list the P value, but it lists the 95% confidence intervals which do not overlap, so it is p<.05

I know that P values mean nothing to you guys, but they mean a lot with the FDA. And that is not an opinion.